Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Negatively charged viral envelopes and capsids are fundamental structural components that facilitate the survival and infectivity of various viruses. The anionic nature of these surfaces often stems from the presence of phosphatidylserine in the lipid envelope or acidic residues within the capsid protein assembly (Soares et al., 2008, Nature Medicine). These components are essential for protecting the viral genome and mediating host cell attachment and entry (Zasloff, 2002, Nature). Therapeutic strategies targeting these surfaces typically employ cationic molecules, such as antimicrobial peptides or synthetic dendrimers like astodrimer sodium, which bind via electrostatic attraction (McCarthy et al., 2005, Molecular Pharmaceutics). This binding can lead to the physical disruption of the viral envelope or the competitive inhibition of viral attachment to host receptors. Because this target is based on conserved physical properties, it provides a pathway for broad-spectrum antiviral development against pathogens like HIV, HSV, and Influenza (Telwatte et al., 2011, Antiviral Research). However, a primary challenge remains the potential for off-target effects on host cell membranes, necessitating high selectivity in drug design.
Electrostatic binding to anionic viral surfaces leading to membrane disruption or inhibition of host cell attachment.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Negatively charged viral envelopes and capsids.